Table 1.
Residues of SARS-CoV-2 Mpro interacting with the three ligands before and during the simulation run.
Types of interactions and residues of main protease involved |
|||||
---|---|---|---|---|---|
Pre-MD interactions |
Interactions during MD simulations |
||||
Ligand bound | Docking score (Kcal/mol) | H-bonds | Hydrophobic interactions and pi-pi stacking | H-bonds | Hydrophobic interactions and pi-pi stacking |
N3 inhibitor | −5.68 | Glu166, Thr190 | His41, Cys44, Met49, Pro52, Tyr54, Phe140, Leu141, Asn142, His164, Met165, Leu167, Pro168, Thr169, Gly170, His172, Asp187, Arg188, Gln189, Ala191, Gln192 | Asn142, Glu166, Arg188, Gln189, Thr190, Gln192 | His41, Ser46, Met49, Lys138, Ser139, Phe140, Asn142, Gly143, Ser144, Cys145, His163, His163, His164, Met165, Glu166, Leu167, Pro168, Thr169, Gly170, His172, Val186, Arg188, Gln189, Thr190, Ala191, Gln192 |
Wi-N | −4.42 | Cys145 | Thr24, Thr25, Thr26, Leu27, His41, Met49, Tyr54, Asn142, Gly143, His164, Met165, Glu166, Arg188, Asp188, Gln189 | Thr26, His41, Cys44, Asn119, Asn142, Gly143, Gln189, Thr190, Gln192 | Gln19, Thr24, Thr25, Thr26, His41, Cys44, Thr45, Ser46, Glu47, Met49, Pro52, Tyr54, Asn119, Asn142, Gly143, Ser144, Cys145, His164, Met165, Glu166, Leu167, Pro168, Gly170, Asp187, Arg188, Gln189, Thr190, Gln192 |
CAPE | −4.79 | Asn142, Glu166 | Leu27, Cys44, Met49, Pro52, Tyr54, Phe140, Leu141, Ser144, Cys145, His163, His164, Met165, Glu166, His172, Asp187, Arg188, Gln189 | Thr25, Cys44, Ser46, Phe140, Asn142, Cys145, Glu166, His172, Gln189, Thr190, Ala191, Gln192 | Thr24, Thr25, Thr26, Pro39, His41, Cys44, Thr45, Ser46, Glu47, Met49, Leu50, Asn51, Cys85, Phe140, Leu141, Asn142, Gly143, Ser144, Cys145, His164, Met165, Glu166, Leu167, Pro168, His172, Phe181, Val186, Asp187, Arg188, Gln189, Thr190, Ala191, Gln192, Ala193, Ala194 |